Shreejaya is the leading manufacturer of Intermediates to manufacture APIs (Active pharmaceuticals ingredients), and Registered starting key materials offering high quality products with the highest level of compliance and integrity to over 20+ companies in different countries. Shreejaya recently reached the milestone of being one among the top 3 Intermediates manufacturers in the India and one among the top companies in Hyderabad. 500 highly trained professionals across departments and ~100 scientists at Shreejaya together to bring world class products to customers.
Laboratories in 100+ states
Laboratory specialists
Material collection points
Patients diagnosed in 2022
Shreejaya believes in maintaining or surpassing the quality standards set by the customer and strives to adhere to highest global regulatory standards.
Shreejaya manufactures Intermediates, Generic APIs and offers Custom Synthesis of Intermediates, APIs to Giant Pharma providing a competitive advantage over the entire life cycle of the products
We predict creating value for all stakeholders by manufacturing high quality Intermediates, Generic APIs, Custom synthesis of Intermediates & APIs to the Global Pharmaceutical industry through balanced management in chemistry.
We predict creating value for all stakeholders by manufacturing high quality Intermediates, Generic APIs, Custom synthesis of Intermediates & APIs to the Global Pharmaceutical industry through balanced management in chemistry.
Testing Begins many varios
suffered alten in some
Testing Begins many varios
suffered alten in some
Testing Begins many varios
suffered alten in some
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscipit loborti excommodo habent claritatem insitamconse quat.Exerci tationlobortis nisl aliquip ex ea commodo habent claritatem insitamconse quat.
Exerci tation ullamcorper suscipit lobortis nisl aliquip ex ea commodo claritatem insitamconse quat.Exerci tation ullamcorper suscip
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
Providing insight-driven transformation to investment banks, wealth and asset mana, exchanges, Finance
USFDAINSPECTED
1ST Audit @ Mar-2016
2nd Audit @ Oct-2022
Next:2026-2027